Philipp B. Staber

5.3k total citations
88 papers, 1.9k citations indexed

About

Philipp B. Staber is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Philipp B. Staber has authored 88 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 31 papers in Oncology and 25 papers in Molecular Biology. Recurrent topics in Philipp B. Staber's work include Lymphoma Diagnosis and Treatment (33 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Acute Myeloid Leukemia Research (14 papers). Philipp B. Staber is often cited by papers focused on Lymphoma Diagnosis and Treatment (33 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Acute Myeloid Leukemia Research (14 papers). Philipp B. Staber collaborates with scholars based in Austria, Germany and United States. Philipp B. Staber's co-authors include Gerald Höefler, Lukas Kenner, Paul Vesely, Werner Linkesch, Daniel G. Tenen, Andelko Hrzenjak, Peter Neumeister, Helmut Denk, Farid Moinfar and Kurt Zatloukal and has published in prestigious journals such as Nature Communications, Blood and The Journal of Immunology.

In The Last Decade

Philipp B. Staber

85 papers receiving 1.8k citations

Peers

Philipp B. Staber
Christopher Ocampo United States
Kiyohiko Hatake Japan
Deepa Bhojwani United States
June‐Won Cheong South Korea
Paloma Martín Spain
Fumihiko Kimura Japan
Wenbin Xiao United States
Diane E. Cole United States
Hiroaki Goto Japan
Jan Leipe Germany
Christopher Ocampo United States
Philipp B. Staber
Citations per year, relative to Philipp B. Staber Philipp B. Staber (= 1×) peers Christopher Ocampo

Countries citing papers authored by Philipp B. Staber

Since Specialization
Citations

This map shows the geographic impact of Philipp B. Staber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp B. Staber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp B. Staber more than expected).

Fields of papers citing papers by Philipp B. Staber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp B. Staber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp B. Staber. The network helps show where Philipp B. Staber may publish in the future.

Co-authorship network of co-authors of Philipp B. Staber

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp B. Staber. A scholar is included among the top collaborators of Philipp B. Staber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp B. Staber. Philipp B. Staber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauer, Karin, Alexander W. Hauswirth, Karoline V. Gleixner, et al.. (2024). BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL. American Journal of Hematology. 99(9). 1721–1731. 15 indexed citations
2.
Herling, Marco, Claire Dearden, Francesco Zaja, et al.. (2024). Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study. Blood Advances. 8(4). 842–845. 2 indexed citations
3.
Zeilinger, Elisabeth L., Claudia Oppenauer, Matthias Knefel, et al.. (2024). Prevalence and biopsychosocial indicators of fatigue in cancer patients. Cancer Medicine. 13(11). e7293–e7293. 2 indexed citations
4.
Pichler, Alexander, Catalina Amador, Ayumi Fujimoto, et al.. (2024). Advances in peripheral T cell lymphomas: pathogenesis, genetic landscapes and emerging therapeutic targets. Histopathology. 86(1). 119–133.
5.
Pichler, Alexander, Christoph Kornauth, Lukas Kazianka, et al.. (2023). Distinct Subtypes of Chemotherapy-Resistant Systemic ALK-Positive Anaplastic Large Cell Lymphoma Demonstrate Long-Term Complete Remissions to Imatinib. Blood. 142(Supplement 1). 1691–1691. 1 indexed citations
6.
Morschhauser, Franck, Katerina Hatzi, Georg Lenz, et al.. (2023). IMMUNE CONTEXTURE ANALYSIS IN POLARIX SUGGESTS RESPONSE TO POLA‐R‐CHP TREATMENT REDUCES TUMOR MICROENVIRONMENT DEPENDENCY. Hematological Oncology. 41(S2). 223–225. 1 indexed citations
7.
Belada, David, Kateřina Kopečková, Juan Bergua, et al.. (2023). Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study. Blood. 142(16). 1348–1358. 12 indexed citations
8.
Zeilinger, Elisabeth L., Matthias Knefel, Jakob Pietschnig, et al.. (2023). The impact of COVID-19 and socioeconomic status on psychological distress in cancer patients. International Journal of Clinical and Health Psychology. 23(4). 100404–100404. 2 indexed citations
9.
Heinemann, Tim, Christoph Kornauth, Yannik Severin, et al.. (2022). Deep Morphology Learning Enhances Ex Vivo Drug Profiling-Based Precision Medicine. Blood Cancer Discovery. 3(6). 502–515. 11 indexed citations
10.
Zeilinger, Elisabeth L., Ingo W. Nader, Wolfgang Wiedermann, et al.. (2022). Latent structure and measurement invariance of the Hospital Anxiety and Depression Scale in cancer outpatients. International Journal of Clinical and Health Psychology. 22(3). 100315–100315. 8 indexed citations
11.
Zeilinger, Elisabeth L., Simone Lubowitzki, Matthias Unseld, et al.. (2022). The impact of COVID‐19 on cancer care of outpatients with low socioeconomic status. International Journal of Cancer. 151(1). 77–82. 13 indexed citations
12.
Porpaczy, Edit, Philipp Wohlfarth, Oliver Königsbrügge, et al.. (2021). Influence of TP53 Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell Era. Cancers. 13(22). 5592–5592. 17 indexed citations
13.
Mayerhoefer, Marius E., Alexander Haug, Ulrich Jäger, et al.. (2020). In Human Visualization of Ibrutinib-Induced CLL Compartment Shift. Cancer Immunology Research. 8(8). 984–989. 8 indexed citations
14.
15.
Hubmann, Rainer, Susanne Schnabl, Christian Schmidl, et al.. (2020). Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL. Cells. 9(6). 1484–1484. 9 indexed citations
16.
Nguyen, Chi Huu, Elisabeth Koller, Emiel van der Kouwe, et al.. (2020). IL2RA Promotes Aggressiveness and Stem Cell–Related Properties of Acute Myeloid Leukemia. Cancer Research. 80(20). 4527–4539. 23 indexed citations
17.
Staber, Philipp B., Marco Herling, Mar Bellido, et al.. (2019). Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia. Blood. 134(14). 1132–1143. 67 indexed citations
18.
Mayerhoefer, Marius E., Markus Raderer, Ulrich Jaeger, et al.. (2018). Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment. European Journal of Nuclear Medicine and Molecular Imaging. 45(6). 931–940. 18 indexed citations
19.
Zollner‐Schwetz, Ines, Holger W. Auner, Astrid H. Paulitsch‐Fuchs, et al.. (2008). Oral and IntestinalCandidaColonization in Patients Undergoing Hematopoietic Stem‐Cell Transplantation. The Journal of Infectious Diseases. 198(1). 150–153. 22 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Ocampo Breakdown of academic impact, for papers by Kiyohiko Hatake Breakdown of academic impact, for papers by Deepa Bhojwani Breakdown of academic impact, for papers by June‐Won Cheong Breakdown of academic impact, for papers by Paloma Martín Breakdown of academic impact, for papers by Fumihiko Kimura Breakdown of academic impact, for papers by Wenbin Xiao Breakdown of academic impact, for papers by Diane E. Cole Breakdown of academic impact, for papers by Hiroaki Goto Breakdown of academic impact, for papers by Jan Leipe
Rankless by CCL
2026